MICA is the key ligand for anti-tumor immunity, activating NKG2D-bearing lymphocytes such as T and NK cells, and its expression is induced in cells under stresses typified by malignant transformation for immune surveillance19, whose impairment has been observed in chronic liver disease with viral infection leading to HCC. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.